Exponent Investor Presentation

Key Metrics – Q3 2023 - ($ Millions, except where noted) 2022 2023 % Change Revenues Before Reimbursements Revenues EBITDA¹ 115.1 125.0 9% 127.2 133.3 5% 34.6 34.5 n/m EBITDA Margin² (%) 30.0% 27.6% Net Income 24.4 24.5 n/m Earnings per share ($) 0.47 0.48 Average diluted shares outstanding (Millions) 52.0 51.6 -1% Billable hours 364,894 379,746 4% Utilization, technical 73% 70% Realized rate increase 2% 4% Technical full time equivalent employees 958 1,050 10% 'Refer to non-GAAP reconciliation on slide 23 2EBITDA Margin % = EBITDA/Revenues before Reimbursements Exponent 23

View entire presentation